Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model

Circulation

Volumn 96, Issue 7, 1997, Pages 2339-2347

  Thiagarajan, Perumal ^a,b   Benedict, Claude R ^a  

^a Health Science Center   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Annexins; Hemodynamics; Phospholipids; Thrombosis

Indexed keywords

LIPOCORTIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BLOOD FLOW VELOCITY; CAROTID ARTERY FLOW; CAROTID ARTERY THROMBOSIS; DOSE RESPONSE; DRUG EFFECT; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030819147     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2339     Document Type: Article

References (39)

1. Kalafatis M, Swords NA, Rand MD, Mann KG. Membrane-dependent reactions in blood coagulation: role of the vitamin K-dependent enzyme complexes. Biocliim BiophysActa, 1994;1227: 113-129.
2. Bevers EM, Comfurius P, Zwaal RF. Mechanisms involved in platelet procoagulant response. Adv Exp Med Biol. 1993;344:195-207.
3. Op den Camp JAF. Lipid asymmetry in membranes. Aimii Rev Med. 1979;48:47-71.
4. Rosing J, van Rijn JLML, Bevers EM, van Dieijen G, Comfurius P, Zwaal RFA. The role of activated platelets in prothrombin and factor X activation. Blood. 1985;65:319-326.
5. Rosing J, Bcvers EM, Comfurius P, Hemker HC, van Dieijen G, Zwaal RFA. Impaired factor X and prothrombin activation associated with decreased anionic phospholipid exposure in platelets from a patient with a bleeding disorder. Blood. 1985;65:1557-1562.
6. Chang CP, Zhao J, Wiedmer T, Sims PJ. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Dial Clicm. 1993;268: 7171-7178.
7. Ravanat C, Archipoff G, Beretz A, Freund G, Cazanave JP, Freyssinet JM. Use of annexin V to demonstrate the role of phosphatidylserine exposure by endothelial cells in maintenance of hemostatic balance. Biochem J. 1992;282:7-13.
8. Van Heerde WL, Poort S, van't veer C, Reutelingsperger CPM, DeGroot PG. Binding of annexin V to endothelial cells: effects of annexin V binding on endothelial cell mediated thrombin formation. Biochem J. 1994;302:305-312.
9. Koopman G. Annexin V for flow cytometric detection of phosphatidylserine expression in B cells undergoing apoptosis. Blood. 1994; 84:15-120.
10. Barton GJ, Newman RH, Freemont PS, Crumpton MJ. Amino acid sequence analysis of annexin super-gene family of proteins. Eur J Biochem. 1991;198:749-760.
11. Funakosht T, Heimark R, Hendrickson L, McMullen BA, Fujikawa K. Human placental anticoagulant proteins: isolation and characterization. Biochemistry. 1987;26:5572-5578.
12. Funakoshi T, Hendrickson LE, McMullen BA, Fujikawa K. Primary structure of human placental anticoagulant protein. Biochemistry. 1987;26:80S7-8092.
13. Iwasaki A, Suda M, Nakao H, Nagoya T, Saino Y, Aral K, Mizoguchi T, Sato F, Yoshizaki H, Hirata M, Miyata T, Shidra Y, Muarata M, Maki M. Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein. J Biochem Tokyo. 1987;102:1261-1273.
14. Van Heerde WL, de Groot PG, Reutelingsperger CPM. The complexity of the phospholipid binding protein annexin V. Ttiromb Haemost. 1995;73:172-179. '
15. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein I, a member of the lipocortin family. J Biol Cliem. 1989;264:7944-7949.
16. Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets: evidence for phosphatidylserine exposure in the procoagulant response to activated platelets. J Biol Chem. 1990;265:17420-17423.
17. Thiagarajan P, Tait JF. Collagen-induced exposure of procoagulant activity in platelets. J Biol Chem. 1991;266:24302-24306.
18. Romoisch J, Seiffge D, Reiner G, Pâques EP, Heimburger N. In vivo antithrombotic effect potency of placental protein 4 (annexin V). Tliromb Res. 1991;61:93-104.
19. Van Ryn McKenna J, Merk H, Muller TH, Buchanan MR, Eisert WG. The effect of heparin and annexin V on fibrin accretion after injury in the jugular vein of rabbits. Tliromb Haemost. 1993;69: 227-230.
20. Van Heerde WL, Sakariassen KS, Hemker HC, Sixma JJ, Reutelingsperger CPM, DeGroot PG. Annexin V inhibits the procoagulant activity of matrices of TNF-stimuIated endothelium under flow conditions. Arterioscler Tliromb. 1994;14:824-830.
21. Berger A, Berendes R, Voges D, Huber R, Démange P. A rapid and efficient purification method for recombinant annexin V for biophysical studies. FEBS Lett. 1993;329:25-28.
22. Kinsky SC. Preparation of liposomes and a spectrometric assay for release of trapped glucose marker. Methods Enzymol. 1974;32: 501-514.
23. Gabriel N, Roberts MF. Spontaneous formation of stable unilamellar vesicles. Biochemistiy. 1984;23:4011-4015.
24. Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6 tetrachlora-3a, 6a, diphenylglycouril. Biochem Biophys Res Commun. 1978;80:849-857.
25. Benedict CR, Refino CJ, Keyt BA, Pakala R, Paoni NF, Thomas GR, Bennet WF. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. Circulation. 1995;92: 3032-3040.
26. Benedict CR, Mathew B, Rex KA, Cartwright J, Sordahl LA. Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombosis model. Circ Res. 19S6;73:58-67.
27. Benedict CR, Ryan J, Wolitzky B, Ramos R, Gerlach M, Tijburg P, Stern D. Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model. J Clin Invest. 1991;88:1761-1765.
28. Benedict CR, Ryan J, Todd J, Kuwabara K, Tijburg O, Cartwright J, Stern D. Active site-blocked Xa prevents thrombus formation in the coronary vasculature in parallel with inhibition of extravascular coagulation in canine thrombosis model. Blood. 1993;81:2059-2066.
29. Lakobsen E, Kierulf P. A modified β-alanine precipitation procedure to prepare fibrinogen free of antithrombin III and plasminogen. Tliromb Res. 1973;3:145-159.
30. Thakur ML, 'Welch MJ, Joist JH, Coleman RE. "'Indium-labelled platelets: studies on preparation and evaluation of an in vitro and in vivo functions. Tliromb Res. 1976;9:345-357.
31. Kane WH, Lindhout MJ, Jackson CM, Majerus P. Factor V-dependent binding of factor X, to human platelets. J Biol Chem. 1980;254:1170-1174.
32. Tracy PB, Nesheim ME, Mann KG. Factor Va-dependent binding of factor Xa to platelets. / Biol Clicm. 19S1;255:1170-1174.
33. Ahmad SS, Rawala-Sheikh R, Walsh PN. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem. 1989:264:3244-3251.
34. Nesheim M, Pittman DD, Giles AR, Fass DN, Wang JH, Slonosky D, Kaufman RJ. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin activated platelets. J Biol Chem. 1991:266:17815-17820.
35. Weiss HJ, Vicie WJ, Lages BA, Rodgers J. Isolated deficiency of platelet procoagulant activity. Am J Med. 1979;67:206-213.
36. Miletich JP, Kane WH, Hoffman SL, Stanford N, Majerus PW. Deficiency of factor Xa-Va binding sites on platelets of a patient with a bleeding disorder. Blood. 1979;54:1015-1022.
37. Ahmad SS, Rawala-Sheik R, Asby B, Walsh PN. Platelet receptormediated factor X activation by factor IXa: high affinity factor IXa receptors are deficient in Scott syndrome. J Clin Invest. 1989;84: 824-828.
38. Stratton J, Dewhurst TA, Kasina S, Reno JM, Cerquira MD, Baskin DG, Tait JF. Selective uptake of radiolabeled annexin V on . acute porcine left atrial thrombi. Circulation. 1995;92:3113-3121.
39. Rao LVM, Tait J, Hoang AD. Binding of annexin V to human ovarian carcinoma cell line (OC-2008): contrasting effect on cell surface factor Vila/tissue factor activity and prothrombinase activity. Tliromb Res. 1992;67:517-531.